Select Page

Infinium Global Research has added a new report on Cardiac Biomarker Diagnostic Kits Market. The report covers the analysis of global as well as regional markets of cardiac biomarker diagnostic kits. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.According to the report, the global cardiac biomarker diagnostic kits market is projected to grow at a CAGR of 8.23% over the forecast period of 2019-2025.

For More Details Get FREE Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/12743

A biomarker is a type of indicator, used to measure the degree of severity of any disease inside the living body. The cardiac biomarker is a substance, which is used to measure the seriousness of the cardiac problem and assist the healthcare professionals for better diagnosis to the patients. There are several types of cardiac biomarker used for different cardiac problems such as cardiac troponin, high sensitive cardiac troponin, CK, CK-MB, myoglobin, and others. The cardiac troponin is a regulatory protein complex, used to diagnose a heart attack and risk stratification. Additionally, it is used to identify the seriousness of the heart problem. The high sensitive cardiac troponin is used to assess the future risk of the cardiac problem in the person. Further, the CK biomarker is used to detect the recurrence of the heart attack in the patients. Moreover, the myoglobin is used with troponin to provide a diagnosis as early as possible.

As per the WHO the CVD (Cardiovascular diseases) is a major cause of death from disease around the world. In 2016, 17.9 million people died from the CVDs problem, which comprises of 31% of the global death from illness. Further, 85% of death due to CVDs was due to heart attack and stroke. The developing and under developing countries reported more death owing to the CVDs problem compared to the developed countries. The lack of basic healthcare infrastructure, shortage of healthcare professionals in the developing and underdeveloped countries are the key factors for more death in these regions as compared to the developed countries. The changing food consumption and living standard is a major factor for the growth of this type of disease around the globe. The growing consumption of nicotine, growing alcoholism, lack of physical activities, the stressful work environment is the major factor responsible for the increasing prevalence of the cardiac problem around the world.

North America is the Leading Region of the Cardiac Biomarker Diagnostic Kits Market

The North America is the leading region of the cardiac biomarker diagnostic kits market, owing to the presence of the large patient pool in this region. As per the American Heart Association, more than 320,000 deaths (out of hospital) occurs every year, in the United States due to the cardiac-related problem. Further, more than 7,20,000 new heart attack and 3,35,000 recurrent heart attack occurs every year in the United States alone. Additionally, persons suffering from this type of problem in other countries as Indian, China prefer to go to the United States of America to get better treatment, owing to the availability of the better health care facility and trained health care professionals. This medical tourism is boosting the growth of the cardiac biomarker diagnostic kits market of the North America. Europe region is the second largest market after North America. The Asia-Pacific is expected to show the high incidence of the cardiac problem in the near future, owing to the changing lifestyle. Further, changing food consumption as smoking, drinking, and fast food preference is increasing the incidence of the cardiac arrest problem in this region.

Cardiac Biomarker Diagnostic Kits Market: Segmentation

The report on global cardiac biomarker diagnostic kits market covers segments such as disease indication, testing, product, and end user. On the basis of disease indication, the sub-markets include angina pectoris, myocardial infraction, cardiac heart failure, and other disease indication. On the basis of testing, the sub-markets include laboratory testing, and point of care testing. On the basis of product, the sub-markets include troponin test kits, CK-MB test kits, myoglobin test kits, BNP test kit, c-reactive protein (HSCRP), and other products. On the basis of end user, the sub-markets include hospitals, clinics, diagnostics centers, and other end users.

Cardiac Biomarker Diagnostic Kits Market: Competitive Landscape

The report provides profiles of the companies in the market such as Ortho Clinical Diagnostics, Randox Laboratories, bioMérieux, Thermo Fisher Scientific, Siemens Healthineers AG, Danaher Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, and Abbott Laboratories.

Browse Detailed TOC and Description of this Exclusive Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-cardiac-biomarker-diagnostic-kits-market

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the Cardiac Biomarker Diagnostic Kits.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.